Red Rock Regeneration Inc is a biotechnology and medical device company located in Toronto, Ontario, Canada. The company is dedicated to developing innovative and affordable products that support bone repair and regeneration. Their notable offering is the Natural Matrix Protein (NMP) series of bone allograft products, launched in partnership with Induce Biologics USA Inc in late 2021. The NMP process is patent-pending and aims to enhance the bioavailability of growth factors naturally found in bone, contributing to its effectiveness in medical applications.

The technology behind Red Rock Regeneration’s products has been utilized in over 1,000 surgeries, demonstrating its acceptance in the medical community. With a small team of 12 employees, the company maintains a focused approach to its operations. Cameron Clokie serves as a director and is involved in the company’s leadership, guiding its contributions to advancements in bone regeneration technology.